InVivo Therapeutics

About:

InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.

Website: http://www.invivotherapeutics.com

Twitter/X: invivo_sci

Top Investors: Lincoln Park Capital Fund, SternAegis, Spencer Trask & Co, Montrose Capital Partners

Description:

InVivo Therapeutics Corporation is a medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injuries. The company was founded in 2005 on the basis of research initiated in Cambridge, Massachusetts, United States.

Total Funding Amount:

$125M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)invivotherapeutics.com

Founders:

Joseph P. Vacanti

Number of Employees:

1-10

Last Funding Date:

2022-10-07

IPO Status:

Public

Industries:

© 2025 bioDAO.ai